Instrument Inactif

Autres langues ACCM SCIE OTC Markets

Actions

ACMSY

US00442Y1010

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

AccuStem Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	20/05
AccuStem Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
AccuStem Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
AccuStem Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
AccuStem Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership	17/07/23
Accustem Sciences, Inc. and Emeritusdx Announce Joint Product Development Agreement and Strategic Partnership	17/07/23
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer	11/07/23
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers (form 8-K)	09/06/23
Accustem Sciences Inc. Announces Resignation of Jeff Fensterer as Chief Operating Officer, Effective as of June 16, 2023	09/06/23
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals	06/06/23
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals	06/06/23
AccuStem Announce Strategic Clinical and Operational Partnership	31/05/23
Accustem Sciences Inc. Announces Strategic Clinical and Operational Partnership	31/05/23
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	05/05/23
AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer	02/05/23
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	15/02/23
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	06/12/22
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	22/11/22
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	16/11/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ACCM SCIE OTC Markets

Actions

ACMSY

US00442Y1010

Autres langues

Filtres